Broader use of medication recommended

PBAC recommends extending eligibility criteria for Covid medication to an additional population group    In an out-of-session consideration, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended changes to the circumstances under which nirmatrelvir and ritonavir (Paxlovid) is available on the PBS. Paxlovid is indicated for patients with mild-to-moderate COVID-19 who are at high risk of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Methadone disaster looming
Next $1m vape haul